Company profile: Immunodiagnostic Systems
1.1 - Company Overview
Company description
- Provider of in-vitro diagnostic solutions for clinical and research laboratories, including the IDS-iSYS multi-discipline automated system, automated and manual immunoassays, endocrinology and autoimmunity assay portfolios, and therapeutic drug monitoring. Development focuses on bone and calcium metabolism, growth, hypertension, and chronic kidney disease.
Products and services
- Automated Immunoassays: Clinical-grade automated assay portfolio for endocrinology and other clinical areas that enhances laboratory efficiency and productivity in clinical settings through automated immunoassay processing
- Endocrinology Portfolio: Specialty-focused tools that assess and manage endocrine conditions with various hormone assays and vitamin D tests for clinical laboratories
- IDS-iSYS Multi-Discipline Automated System: Laboratory-grade instrument engineered to automate specialty testing in clinical and research laboratories, delivering flexible multi-discipline assay processing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immunodiagnostic Systems
CML HealthCare
HQ: Canada
Website
- Description: Provider of community-based laboratory testing services in Ontario and the largest community-based medical imaging services in Canada, supporting millions of patients and referring physicians in diagnosis and health management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CML HealthCare company profile →
Numares
HQ: Germany
Website
- Description: Provider of software-based diagnostic test systems and commercial NMR analytics in Europe, offering the full scope of up-to-date NMR analytics from one source, with expert assistance for optimal results; fast, cost-efficient, and reliable.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Numares company profile →
Hemagen Diagnostics
HQ: United States
Website
- Description: Provider of product distribution via partnerships with major IVD companies where synergies exist.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemagen Diagnostics company profile →
DRG International
HQ: United States
Website
- Description: Provider of clinical diagnostic and research ELISAs with distributors, and manufacturer of the DRG:HYBRiD-XL®, a fully automated analyzer for Immunoassays and Clinical Chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DRG International company profile →
EraGen Biosciences
HQ: United States
Website
- Description: Provider of molecular reagent products and software for research, diagnostics, and clinical testing, offering molecular diagnostic assays for the early detection and monitoring of cancer, genetic, and infectious diseases, as well as genetic-based conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EraGen Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immunodiagnostic Systems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immunodiagnostic Systems
2.2 - Growth funds investing in similar companies to Immunodiagnostic Systems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immunodiagnostic Systems
4.2 - Public trading comparable groups for Immunodiagnostic Systems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →